The crystal structure of bis(1,1,1-trifluoro-4-(naphthalen-2-yl)-4-oxobut-2-en-2-olato)palladium(II), C ₂₈ H ₁₆ F ₆ O ₄ Pd

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1The crystal structure of bis[(4-bromophenyl)(picolinoyl)amide-κ ² N,N′]palladium(II), C ₂₄ H ₁₆ Br ₂ N ₄ O ₂ PdOriginal Research · 2026
2. 2The crystal structure of dichlorido-(<i>N</i>-isopropyl-<i>N</i>-(pyridin-2-ylmethyl)propan-2-amine-<i>κ</i> ² <i>N</i>, <i>N</i>′)palladium(II), C₁₂H₂₀N₂PdCl₂2024
3. 3Crystal structure of bis{2-[5-(3,4,5-trimethoxyphenyl)-4<i>H</i>-1,2,4-triazol-3-yl]pyridine}palladium(II) bis(trifluoroacetate) trifluoroacetic acid disolvate2024
4. 4Crystal structure and Hirshfeld surface analysis of dichlorido[2-(3-cyclopentyl-1,2,4-triazol-5-yl-κ<i>N</i> ⁴)pyridine-κ<i>N</i>]palladium(II) dimethylformamide monosolvate2024
5. 5Crystal structure of 1,7-diazonia-4,10-diazacyclododecane tetrakis(thiocyanato- κS )palladate(II), C 12 H 22 N 8 PdS 4Original Research · 2026